Determinants of survival following heart transplantation in adults with congenital heart disease

Abstract Background Adult patients surviving with congenital heart disease (ACHD) is growing. We examine the factors associated with heart transplant outcomes in this challenging population with complex anatomy requiring redo-surgeries. Methods We reviewed the United Network for Organ Sharing-Standa...

Full description

Bibliographic Details
Main Authors: Hüseyin Sicim, Pierre Emmanuel Noly, Suyash Naik, Vikram Sood, Richard G. Ohye, Jonathan W. Haft, Keith D. Aaronson, Francis D. Pagani, Ming-Sing Si, Paul C. Tang
Format: Article
Language:English
Published: BMC 2024-02-01
Series:Journal of Cardiothoracic Surgery
Subjects:
Online Access:https://doi.org/10.1186/s13019-024-02509-0
_version_ 1797273359591931904
author Hüseyin Sicim
Pierre Emmanuel Noly
Suyash Naik
Vikram Sood
Richard G. Ohye
Jonathan W. Haft
Keith D. Aaronson
Francis D. Pagani
Ming-Sing Si
Paul C. Tang
author_facet Hüseyin Sicim
Pierre Emmanuel Noly
Suyash Naik
Vikram Sood
Richard G. Ohye
Jonathan W. Haft
Keith D. Aaronson
Francis D. Pagani
Ming-Sing Si
Paul C. Tang
author_sort Hüseyin Sicim
collection DOAJ
description Abstract Background Adult patients surviving with congenital heart disease (ACHD) is growing. We examine the factors associated with heart transplant outcomes in this challenging population with complex anatomy requiring redo-surgeries. Methods We reviewed the United Network for Organ Sharing-Standard Transplant Analysis and Research database and analyzed 35,952 heart transplants from January 1st, 2000, to September 30th, 2018. We compared transplant characteristics for ischemic cardiomyopathy (ICM) (n = 14,236), nonischemic cardiomyopathy (NICM) (n = 20,676), and ACHD (n = 1040). Mean follow-up was 6.20 ± 4.84 years. Kaplan–Meier survival curves and Cox-proportional hazards analysis were used to analyze survival data. Results Multivariable analysis confirmed that ACHD was associated greater in-hospital death compared to ICM (HR = 0.54, P < 0.001) and NICM (HR = 0.46, P < 0.001). Notable factors associated with increased mortality were history of cerebrovascular disease (HR = 1.11, P = 0.026), prior history of malignancy (HR = 1.12, P = 0.006), pre-transplant biventricular support (HR = 1.12, P = 0.069), postoperative stroke (HR = 1.47, P < 0.001) and postoperative dialysis (HR = 1.71, P < 0.001). ACHD transplants had a longer donor heart ischemic time (P < 0.001) and trend towards more deaths from primary graft dysfunction (P = 0.07). In-hospital deaths were more likely with ACHD and use of mechanical support such as use of right ventricular assist device (HR = 2.20, P = 0.049), biventricular support (HR = 1.62, P < 0.001) and extracorporeal membrane oxygenation (HR = 2.36, P < 0.001). Conditional survival after censoring hospital deaths was significantly higher in ACHD (P < 0.001). Conclusion Heart transplant in ACHD is associated with a higher post-operative mortality given anatomical complexity but a better long-term conditional survival. Normothermic donor heart perfusion may improve outcomes in the ACHD population by reducing the impact of longer ischemic times.
first_indexed 2024-03-07T14:42:14Z
format Article
id doaj.art-f157ad6dcaea4c91b6ab733b588aca39
institution Directory Open Access Journal
issn 1749-8090
language English
last_indexed 2024-03-07T14:42:14Z
publishDate 2024-02-01
publisher BMC
record_format Article
series Journal of Cardiothoracic Surgery
spelling doaj.art-f157ad6dcaea4c91b6ab733b588aca392024-03-05T20:18:54ZengBMCJournal of Cardiothoracic Surgery1749-80902024-02-011911910.1186/s13019-024-02509-0Determinants of survival following heart transplantation in adults with congenital heart diseaseHüseyin Sicim0Pierre Emmanuel Noly1Suyash Naik2Vikram Sood3Richard G. Ohye4Jonathan W. Haft5Keith D. Aaronson6Francis D. Pagani7Ming-Sing Si8Paul C. Tang9Department of Cardiac Surgery, University of Michigan Frankel Cardiovascular CenterDepartment of Cardiac Surgery, Université de MontréalDepartment of Cardiac Surgery, University of Michigan Frankel Cardiovascular CenterDepartment of Cardiac Surgery, University of Michigan Frankel Cardiovascular CenterDepartment of Cardiac Surgery, University of Michigan Frankel Cardiovascular CenterDepartment of Cardiac Surgery, University of Michigan Frankel Cardiovascular CenterDepartment of Internal Medicine, Division of Cardiovascular Medicine, University of Michigan Frankel Cardiovascular CenterDepartment of Cardiac Surgery, University of Michigan Frankel Cardiovascular CenterDepartment of Surgery, Division of Cardiac Surgery, University of California Los AngelesDepartment of Cardiac Surgery, University of Michigan Frankel Cardiovascular CenterAbstract Background Adult patients surviving with congenital heart disease (ACHD) is growing. We examine the factors associated with heart transplant outcomes in this challenging population with complex anatomy requiring redo-surgeries. Methods We reviewed the United Network for Organ Sharing-Standard Transplant Analysis and Research database and analyzed 35,952 heart transplants from January 1st, 2000, to September 30th, 2018. We compared transplant characteristics for ischemic cardiomyopathy (ICM) (n = 14,236), nonischemic cardiomyopathy (NICM) (n = 20,676), and ACHD (n = 1040). Mean follow-up was 6.20 ± 4.84 years. Kaplan–Meier survival curves and Cox-proportional hazards analysis were used to analyze survival data. Results Multivariable analysis confirmed that ACHD was associated greater in-hospital death compared to ICM (HR = 0.54, P < 0.001) and NICM (HR = 0.46, P < 0.001). Notable factors associated with increased mortality were history of cerebrovascular disease (HR = 1.11, P = 0.026), prior history of malignancy (HR = 1.12, P = 0.006), pre-transplant biventricular support (HR = 1.12, P = 0.069), postoperative stroke (HR = 1.47, P < 0.001) and postoperative dialysis (HR = 1.71, P < 0.001). ACHD transplants had a longer donor heart ischemic time (P < 0.001) and trend towards more deaths from primary graft dysfunction (P = 0.07). In-hospital deaths were more likely with ACHD and use of mechanical support such as use of right ventricular assist device (HR = 2.20, P = 0.049), biventricular support (HR = 1.62, P < 0.001) and extracorporeal membrane oxygenation (HR = 2.36, P < 0.001). Conditional survival after censoring hospital deaths was significantly higher in ACHD (P < 0.001). Conclusion Heart transplant in ACHD is associated with a higher post-operative mortality given anatomical complexity but a better long-term conditional survival. Normothermic donor heart perfusion may improve outcomes in the ACHD population by reducing the impact of longer ischemic times.https://doi.org/10.1186/s13019-024-02509-0Heart transplantHeart failureCongenital heart diseaseOutcomes
spellingShingle Hüseyin Sicim
Pierre Emmanuel Noly
Suyash Naik
Vikram Sood
Richard G. Ohye
Jonathan W. Haft
Keith D. Aaronson
Francis D. Pagani
Ming-Sing Si
Paul C. Tang
Determinants of survival following heart transplantation in adults with congenital heart disease
Journal of Cardiothoracic Surgery
Heart transplant
Heart failure
Congenital heart disease
Outcomes
title Determinants of survival following heart transplantation in adults with congenital heart disease
title_full Determinants of survival following heart transplantation in adults with congenital heart disease
title_fullStr Determinants of survival following heart transplantation in adults with congenital heart disease
title_full_unstemmed Determinants of survival following heart transplantation in adults with congenital heart disease
title_short Determinants of survival following heart transplantation in adults with congenital heart disease
title_sort determinants of survival following heart transplantation in adults with congenital heart disease
topic Heart transplant
Heart failure
Congenital heart disease
Outcomes
url https://doi.org/10.1186/s13019-024-02509-0
work_keys_str_mv AT huseyinsicim determinantsofsurvivalfollowinghearttransplantationinadultswithcongenitalheartdisease
AT pierreemmanuelnoly determinantsofsurvivalfollowinghearttransplantationinadultswithcongenitalheartdisease
AT suyashnaik determinantsofsurvivalfollowinghearttransplantationinadultswithcongenitalheartdisease
AT vikramsood determinantsofsurvivalfollowinghearttransplantationinadultswithcongenitalheartdisease
AT richardgohye determinantsofsurvivalfollowinghearttransplantationinadultswithcongenitalheartdisease
AT jonathanwhaft determinantsofsurvivalfollowinghearttransplantationinadultswithcongenitalheartdisease
AT keithdaaronson determinantsofsurvivalfollowinghearttransplantationinadultswithcongenitalheartdisease
AT francisdpagani determinantsofsurvivalfollowinghearttransplantationinadultswithcongenitalheartdisease
AT mingsingsi determinantsofsurvivalfollowinghearttransplantationinadultswithcongenitalheartdisease
AT paulctang determinantsofsurvivalfollowinghearttransplantationinadultswithcongenitalheartdisease